Literature DB >> 33449295

68Ga-FAPI PET/CT imaging in a patient with thyroiditis.

Yue Zhou1, Jing He2, Yue Chen3.   

Abstract

Entities:  

Year:  2021        PMID: 33449295     DOI: 10.1007/s12020-021-02605-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  2 in total

1.  68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Authors:  Clemens Kratochwil; Paul Flechsig; Thomas Lindner; Labidi Abderrahim; Annette Altmann; Walter Mier; Sebastian Adeberg; Hendrik Rathke; Manuel Röhrich; Hauke Winter; Peter K Plinkert; Frederik Marme; Matthias Lang; Hans-Ulrich Kauczor; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

2.  Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT.

Authors:  Yaping Luo; Qingqing Pan; Wen Zhang; Fang Li
Journal:  Clin Nucl Med       Date:  2020-04       Impact factor: 7.794

  2 in total
  3 in total

Review 1.  Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Authors:  Mengting Li; Muhsin H Younis; Yongxue Zhang; Weibo Cai; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-31       Impact factor: 10.057

Review 2.  FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century.

Authors:  Rong Huang; Yu Pu; Shun Huang; Conghui Yang; Fake Yang; Yongzhu Pu; Jindan Li; Long Chen; Yunchao Huang
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

3.  Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?

Authors:  Hessamoddin Roustaei; Zahra Kiamanesh; Emran Askari; Ramin Sadeghi; Kamran Aryana; Giorgio Treglia
Journal:  Contrast Media Mol Imaging       Date:  2022-02-22       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.